Description
GLT2 Diary is a companion for anyone starting or continuing sodium‑glucose cotransporter‑2 inhibitor therapy.
Why you’ll love it
One‑tap logging – Record daily weight and common SGLT2‑related symptoms (fatigue, hypotension, light‑headedness, genital itching, dysuria, fever) in just a few seconds.
Smart calendar view – A color‑coded 28‑day heat map instantly shows how your weight and symptoms change over time, with a special highlight for your SGLT2 start date.
HealthKit sync – Optionally pull the latest body‑mass data directly from Apple Health so you never type the same number twice.
Custom feedback – Choose alert, vibration, or both when a record is saved—perfect for discreet reminders.
Privacy first – All data stays on your device; no accounts, no cloud upload.
Lightweight & ad‑supported – Runs smoothly on iPhone and iPad, with a single unobtrusive banner ad to keep the app free.
What are SGLT2 inhibitors?
Sodium–glucose co‑transporter 2 inhibitors (often abbreviated SGLT2 i) are oral medicines that block the SGLT2 pumps in the kidney’s proximal tubule. By preventing glucose re‑uptake, they promote glycosuria, lower blood sugar, and gently lower blood pressure. Large outcome trials have also shown benefits in heart failure and chronic kidney disease, leading to their widespread use beyond diabetes care.
e.g.,
Brand name Generic name
Invokana® canagliflozin
Farxiga® dapagliflozin
Jardiance® empagliflozin
Steglatro® ertugliflozin
Brenzavvy™ bexagliflozin
Inpefa™ sotagliflozin
Medical disclaimer: SGLT2 Diary is for informational tracking only and does not replace professional medical advice. Always consult your healthcare provider about diagnosis or treatment decisions.